Should You Buy, Sell or Hold Merck (MRK) Ahead of Q2 Earnings?

Merck (MRK) will report its second-quarter earnings on Jul 30, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.85 billion and $2.15 per share, respectively. Earnings estimates for Merck have risen from $8.58 to $8.60 per share over the past seven days. For 2025, earnings estimates have risen from $9.94 to $9.96 per share over the same timeframe.Image Source: Zacks Investment ResearchEarnings Surprise HistoryThe healthcare bellwether’s performance has been solid, with ...